<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T07:51:20Z</responseDate>
  <request identifier="oai:figshare.com:article/33938163" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33938163</identifier>
        <datestamp>2026-09-18T17:37:33Z</datestamp>
        <setSpec>category_13</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Categorisation of alpha-1 antitrypsin deficiency genotypes (SD = severe deficiency, NS = non-severe, N = normal).&lt;/p&gt;</dc:title>
          <dc:creator>Joshua De Soyza (24121959)</dc:creator>
          <dc:creator>Paul Ellis (6758159)</dc:creator>
          <dc:creator>Daniella Spittle (25073274)</dc:creator>
          <dc:creator>Anita Pye (17896389)</dc:creator>
          <dc:creator>Alice M. Turner (7950329)</dc:creator>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>minor adjustments reflecting</dc:subject>
          <dc:subject>mean age 54</dc:subject>
          <dc:subject>larger multicentre datasets</dc:subject>
          <dc:subject>findings provide evidence</dc:subject>
          <dc:subject>05 &amp;# 8211</dc:subject>
          <dc:subject>severe disease respectively</dc:subject>
          <dc:subject>severity score derived</dc:subject>
          <dc:subject>sectional data collection</dc:subject>
          <dc:subject>general bronchiectasis populations</dc:subject>
          <dc:subject>bronchiectasis severity index</dc:subject>
          <dc:subject>hazard ratio 1</dc:subject>
          <dc:subject>1 antitrypsin deficiency</dc:subject>
          <dc:subject>lung function decline</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>although prospective validation</dc:subject>
          <dc:subject>birmingham aatd registry</dc:subject>
          <dc:subject>cause bronchiectasis cohorts</dc:subject>
          <dc:subject>1 %, 7</dc:subject>
          <dc:subject>median bsi score</dc:subject>
          <dc:subject>7 %, 23</dc:subject>
          <dc:subject>severe aatd genotypes</dc:subject>
          <dc:subject>severe genotypes</dc:subject>
          <dc:subject>7 %,</dc:subject>
          <dc:subject>cause bronchiectasis</dc:subject>
          <dc:subject>sgrq score</dc:subject>
          <dc:subject>clinical data</dc:subject>
          <dc:subject>7 years</dc:subject>
          <dc:subject>confirmed bronchiectasis</dc:subject>
          <dc:subject>4 %,</dc:subject>
          <dc:subject>ci 1</dc:subject>
          <dc:subject>bsi score</dc:subject>
          <dc:subject>zz genotype</dc:subject>
          <dc:subject>study aimed</dc:subject>
          <dc:subject>specifically evaluated</dc:subject>
          <dc:subject>significant association</dc:subject>
          <dc:subject>sgrq ).</dc:subject>
          <dc:subject>related quality</dc:subject>
          <dc:subject>prognostic tool</dc:subject>
          <dc:subject>male ),</dc:subject>
          <dc:subject>increasingly recognised</dc:subject>
          <dc:subject>greater decline</dc:subject>
          <dc:subject>gas transfer</dc:subject>
          <dc:subject>alternative causes</dc:subject>
          <dc:subject>8 %.</dc:subject>
          <dc:subject>14 ).</dc:subject>
          <dc:subject>002 ).</dc:subject>
          <dc:subject>001 ),</dc:subject>
          <dc:description>&lt;p&gt;Categorisation of alpha-1 antitrypsin deficiency genotypes (SD = severe deficiency, NS = non-severe, N = normal).&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T17:37:31Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0355956.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Categorisation_of_alpha-1_antitrypsin_deficiency_genotypes_SD_severe_deficiency_NS_non-severe_N_normal_p_/33938163</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
